{"brief_title": "Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections", "brief_summary": "Phase IV Open-Label Foot Infection Study is being conducted to generate comparative Efficacy and Safety data in Diabetic Inpatients.", "condition": "Diabetic Foot", "intervention_type": "Drug", "intervention_name": "Piperacillin/Tazobactam", "criteria": "Inclusion Criteria - Patients with diabetes mellitus - Inpatient - Have 1 or more infected ulcer(s) below the ankle Exclusion Criteria - Must not have gangrene or severely impaired arterial supply in your foot - Must not have a bone infection in the area of your ulcer - Must not have allergies to penicillins", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00044746.xml"}